Trastuzumab emtansine in patients with metastatic HER2-positive breast cancer

Trial Profile

Trastuzumab emtansine in patients with metastatic HER2-positive breast cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2008

At a glance

  • Drugs Trastuzumab emtansine (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Sep 2008 New trial record.
    • 06 Sep 2008 Interim findings presented at the American Society of Clinical Oncology's Breast Cancer Symposium in September.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top